The best solution to improve efficiency and productivity in immunofluorescence.
L21-01 IFA PROCESSOR is a laboratory instrument for the automatic preparation of IFA slides, compatible with EPIQO technology.
L21-01 IFA PROCESSOR is a liquid handling system for the fully automatic preparation of IFA slides, including the application of the coverslip.
This laboratory device will complies with the new EU-IVDR regulation.
Thanks to the capacity of 15 IFA slides, L21-01 IFA PROCESSOR is at the top of the instrument range in terms of workload related to its compact dimensions.
L21-01 IFA PROCESSOR has been designed to guarantee full compatibility with EPIQO IFA scanner technology: the combination of the two instruments generates the definitive combined full Automation solution for the laboratory, optimizing a large load capacity in a small space.
Technical Specifications
Flexibility : one aspiration and dispensing needles, 1 aspiration only needle for IFA wash cycles
Coverslipper application system using a dedicated sub-device
Possibility to read Barcodes for samples, reagents, slides
150 samples with racks of 30 samples each
20 positions for Controls/Calibrators (different quantities are possible depending on the diameter of the control bottle)
9 positions for conjugate (FITC) type bottles
4 sample diluent positions
288 predilution/titration deepwell
15 slides
3 external lines, 1 wash buffers, 1 System Diluent and 1 Waste Rack
Customers rely on us for quality, experience in manufacturing IVD medical devices and our capabilities in developing new products. And they talk about it, worldwide.
Microscopic imaging of Inflammatory Bowel Disease (IBD) and Non-IBD Colitis on digital slides: The Italian Group-IBD Pathologists experience.
Salviato T, Bonetti LR, Mangogna A, Leoncini G, Cadei M, Caprioli F, Armuzzi A, Daperno M, Villanacci V.
Pathol Res Pract. 2020 Nov;216(11):153189. doi: 10.1016/j.prp.2020.153189. Epub 2020 Aug 29.PMID: 32906010
Fully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation study.
van der Logt EM, Kuperus DA, van Setten JW, van den Heuvel MC, Boers JE, Schuuring E, Kibbelaar RE.